Are you Dr. Gullo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 69 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5008 Brittonfield Pkwy
Suite 700
East Syracuse, NY 13057Phone+1 315-472-7504Fax+1 315-479-8639
Summary
- Dr. John Gullo, MD is an oncologist in East Syracuse, New York. He is currently licensed to practice medicine in New York, North Carolina, and Maine. He is affiliated with Mid Coast Hospital, Pen Bay Medical Center, and St. Mary's Regional Medical Center.
Education & Training
Georgetown University HospitalFellowship, Medical Oncology, 1979
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1972 - 1975- SUNY Upstate Medical UniversityInternship, Transitional Year, 1971 - 1972
SUNY Upstate Medical UniversityClass of 1971
Certifications & Licensure
ME State Medical License 2017 - 2025
MA State Medical License 2014 - 2023
NC State Medical License 2022 - 2022
NY State Medical License 1979 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 618 citationsA prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology ...Jacob J. Lokich, James D. Ahlgren, John J. Gullo, James A. Philips, John G. Fryer
Journal of Clinical Oncology. 1989-04-01 - 1 citationsDichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study.Galen L. Wampler, James D. Ahlgren, Jacob J. Lokich, John J. Gullo, James A. Phillips
American Journal of Clinical Oncology. 1991-10-01 - 143 citationsThe use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.Stephen L. Graziano, Rani Mazid, Nancy Newman, Arthur H. Tatum, Albert Oler
Journal of Clinical Oncology. 1989-10-01
Professional Memberships
- Member
